These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 6293638

  • 1. Converting-enzyme inhibitor enalapril (MK421) in treatment of hypertension with renal artery stenosis.
    Hodsman GP, Brown JJ, Davies DL, Fraser R, Lever AF, Morton JJ, Murray GD, Robertson JI.
    Br Med J (Clin Res Ed); 1982 Dec 11; 285(6356):1697-9. PubMed ID: 6293638
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Advances in the medical management of renovascular hypertension.
    Vidt DG.
    Urol Clin North Am; 1984 Aug 11; 11(3):417-24. PubMed ID: 6087531
    [Abstract] [Full Text] [Related]

  • 8. Enalapril in hypertension with renal artery stenosis: long-term follow-up and effects on renal function.
    Tillman DM, Malatino LS, Cumming AM, Hodsman GP, Leckie BJ, Lever AF, Morton JJ, Webb DJ, Robertson JI.
    J Hypertens Suppl; 1984 Dec 11; 2(2):S93-100. PubMed ID: 6100883
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Mechanism of deterioration in renal function in patients with renovascular hypertension treated with enalapril.
    Bender W, La France N, Walker WG.
    Hypertension; 1984 Dec 11; 6(2 Pt 2):I193-7. PubMed ID: 6327522
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Role of angiotensin converting enzyme inhibitors in essential and renal hypertension. Effects of captopril and enalapril on renin-angiotensin-aldosterone, renal function and hemodynamics, salt and water excretion, and body fluid composition.
    Bauer JH.
    Am J Med; 1984 Aug 20; 77(2A):43-51. PubMed ID: 6206722
    [Abstract] [Full Text] [Related]

  • 16. Use of the converting enzyme inhibitor enalapril in renovascular hypertension. Effect on blood pressure, renal function, and the renin-angiotensin-aldosterone system.
    Reams GP, Bauer JH, Gaddy P.
    Hypertension; 1986 Apr 20; 8(4):290-7. PubMed ID: 3007351
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Renovascular hypertension: treatment with the oral angiotensin-converting enzyme inhibitor enalapril.
    Jackson B, Murphy BF, Johnston CI, Kincaid-Smith P, Whitworth JA.
    Am J Nephrol; 1986 Apr 20; 6(3):182-6. PubMed ID: 3017107
    [Abstract] [Full Text] [Related]

  • 19. [Hypertension therapy in patients with renal artery stenosis].
    Vogt B, Maillard M, Burnier M.
    Ther Umsch; 2012 May 20; 69(5):279-81. PubMed ID: 22547359
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.